Corneal transplantation is primarily indicated for conditions that cause corneal clouding, scarring, or structural distortion, including keratoconus, Fuchs' endothelial dystrophy, bullous keratopathy, and severe infectious keratitis.
The corneal transplantation market size is expected to reach US$ 922.29 Million by 2034 from US$ 535.63 Million in 2025. The market is anticipated to register a...
The global High Content Screening Market is experiencing significant growth as pharmaceutical companies, biotechnology organizations, and research institutions increasingly focus on advanced drug discovery and cellular analysis technologies. The market was valued at US$ 764.40 million in 2025 and is projected to reach US$ 1,642.20 million by 2034, registering a compound annual growth rate of...
Global Mesotherapy Market Accelerates Rapidly as Minimally Invasive Aesthetics, Targeted Biorevitalization, and Advanced Transdermal Delivery Systems Reshape Cosmetic Dermatology
The global aesthetic medicine and dermatological intervention landscape is undergoing a decisive paradigm shift, transitioning from aggressive surgical procedures toward personalized, minimally invasive regenerative...
Global 3D Cell Culture Market Climbs from USD 1.80 Billion in 2025 toward USD 5.09 Billion by 2032, Expanding at an Accelerated 16.00% CAGR as Organoids, Microfluidic Organ-on-a-Chip Systems, and Non-Animal Testing Mandates Transform Preclinical Drug Discovery
Strategic Executive Intelligence on Scaffold-Based Hydrogels, Scaffold-Free Hanging Drop and Magnetic Levitation Platforms,...
Every biologic drug, vaccine, and cell-based therapy begins its life in a dish which is why the nutrient solutions and cell populations that keep those cells alive have quietly become one of biotech's most strategically important supply categories. As biopharma pipelines swell with monoclonal antibodies, cell therapies, and treatments for rare and chronic diseases, demand for reliable,...
Polaris Market Research today announced findings from its latest report, projecting the U.S. cell culture media & cell lines market to grow from USD 1.90 billion in 2024 to USD 4.57 billion by 2034, at a CAGR of 9.20%. The report profiles 11 leading companies across three market segments, covering product, application, and end use.
Analyst Commentary on U.S. Cell Culture Media & Cell...
The India organoids market is on the cusp of a transformative era that will fundamentally redefine biomedical research and personalized medicine in the country. The convergence of advanced stem cell technologies, 3D bioprinting, artificial intelligence, and strategic collaborations is creating a new paradigm where organoids become integral to drug discovery, disease modeling, and regenerative...
"
According to the latest report published by Data Bridge Market Research, the Cell Therapy Manufacturing Platforms Market
CAGR Value
The global Cell Therapy Manufacturing Platforms market size was valued at USD 3.48 billion in 2025and is expected to reach USD 11.97 billion by 2033, at a CAGR of 16.70% during the forecast period
Global Cell...
Global Lab-on-a-Chip Market Set to Surpass USD 16.37 Billion Driven by Decentralized Point-of-Care Diagnostics, Microfluidic Drug Discovery, and Organ-on-Chip Breakthroughs
The international life sciences, clinical diagnostics, and biotechnology ecosystems are undergoing an architectural transition toward micro-scale operational integration. According to an extensive industry evaluation...
According to the latest report published by Data Bridge Market Research, the Human Embryonic Stem Cell Market
The global human embryonic stem cell market size was valued at USD 2.20 billion in 2024 and is projected to reach USD 4.23 billion by 2032, with a CAGR of 8.50% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value,...
According to a new report by Polaris Market Research, the global mesenchymal stem cells (MSCs) market was valued at USD 3.37 billion in 2024 and is projected to reach USD 11.26 billion by 2034, expanding at a CAGR of 12.9% over the forecast period. Growth is underpinned by rising demand for personalized medicine, advancing biomanufacturing techniques, and expanding applications of...
According to a new report by Polaris Market Research, the global mesenchymal stem cells (MSCs) market was valued at USD 3.37 billion in 2024 and is projected to reach USD 11.26 billion by 2034, expanding at a CAGR of 12.9% over the forecast period. Growth is underpinned by rising demand for personalized medicine, advancing biomanufacturing techniques, and expanding applications of...